128 related articles for article (PubMed ID: 6413527)
1. Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin.
Rowe RC; Cowden EA; Faiman C; Friesen HG
J Clin Endocrinol Metab; 1983 Nov; 57(5):942-6. PubMed ID: 6413527
[TBL] [Abstract][Full Text] [Related]
2. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of biological activity of prolactin molecular weight variants in human sera.
Whitaker MD; Klee GG; Kao PC; Randall RV; Heser DW
J Clin Endocrinol Metab; 1984 May; 58(5):826-30. PubMed ID: 6707188
[TBL] [Abstract][Full Text] [Related]
4. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
Ataya KM; Subramanian MG; Lawson DM; Gala RR
J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
[TBL] [Abstract][Full Text] [Related]
5. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
Rose DP; Berke B; Cohen LA
Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Nb2 lymphoma cell bioassay with immunoassay for human prolactin: the role of estrogen.
Nader S; Warner MD; Friesen HG; Peabody CA
J Endocrinol Invest; 1992 Apr; 15(4):303-5. PubMed ID: 1512421
[TBL] [Abstract][Full Text] [Related]
7. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
8. Rat lymphoma cell bioassay for prolactin: observations on its use and comparison with radioimmunoassay.
Lawson DM; Sensui N; Haisenleder DH; Gala RR
Life Sci; 1982 Dec; 31(26):3063-70. PubMed ID: 7162366
[TBL] [Abstract][Full Text] [Related]
9. Correlation and comparison of Nb2 lymphoma cell bioassay with radioimmunoassay for human prolactin.
Subramanian MG; Spirtos NJ; Moghissi KS; Magyar DM; Hayes MF; Gala RR
Fertil Steril; 1984 Dec; 42(6):870-4. PubMed ID: 6500079
[TBL] [Abstract][Full Text] [Related]
10. Serum specifically potentiates the mitogenic response of Nb2 lymphoma cells to rat prolactin.
Moy JA; Lawson DM
Endocrinology; 1988 Sep; 123(3):1314-9. PubMed ID: 3402387
[TBL] [Abstract][Full Text] [Related]
11. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
Parsons JA; Peterson EK; Hartfel MA
Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
[TBL] [Abstract][Full Text] [Related]
12. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
[TBL] [Abstract][Full Text] [Related]
13. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
[TBL] [Abstract][Full Text] [Related]
14. Comparison between rat prolactin radioimmunoassay and bioassay values under different experimental and physiological conditions.
Owens RE; Casanueva FF; Friesen HG
Mol Cell Endocrinol; 1985 Feb; 39(2):131-40. PubMed ID: 3920095
[TBL] [Abstract][Full Text] [Related]
15. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
Smith CR; Butler J; Hashim I; Norman MR
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-like biological activity in the pituitary glands of the marsupial Monodelphis domestica and of the amphibian Rana pipiens detected by a colorimetric Nb2 lymphoma cell proliferation assay.
Kacsóh B
Proc Soc Exp Biol Med; 1997 Feb; 214(2):146-55. PubMed ID: 9034132
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of serum prolactin in patients with primary hypothyroidism.
Smith CR; Butler J; Norman MR
Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():540-5. PubMed ID: 3232956
[TBL] [Abstract][Full Text] [Related]
18. Characterization of long term hormonal cell cultures from the MtT/w15 prolactin- and growth hormone-secreting rat pituitary tumor.
McKeel DW; Hajek SA
Endocrinology; 1981 Apr; 108(4):1571-86. PubMed ID: 7472284
[TBL] [Abstract][Full Text] [Related]
19. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
[TBL] [Abstract][Full Text] [Related]
20. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
J Med; 1986; 17(1):25-39. PubMed ID: 3035040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
